Skip to main content

Apresoline Side Effects

Generic name: hydralazine

Medically reviewed by Drugs.com. Last updated on Aug 21, 2024.

Note: This document provides detailed information about Apresoline Side Effects associated with hydralazine. Some dosage forms listed on this page may not apply specifically to the brand name Apresoline.

Applies to hydralazine: oral tablet.

Other dosage forms:

Serious side effects of Apresoline

Along with its needed effects, hydralazine (the active ingredient contained in Apresoline) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking hydralazine:

More common

  • arm, back, or jaw pain
  • chest pain or discomfort
  • chest tightness or heaviness
  • fast, pounding, or irregular heartbeat or pulse
  • nausea
  • shortness of breath
  • sweating

Less common

  • black, tarry stools
  • blindness or vision changes
  • blisters on the skin
  • blurred vision
  • burning of the face or mouth
  • burning, crawling, itching, numbness, painful, prickling, "pins and needles", or tingling feelings
  • chills
  • clumsiness or unsteadiness
  • confusion
  • cough
  • difficult or labored breathing
  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
  • fever and sore throat
  • general feeling of discomfort or illness or weakness
  • joint pain
  • lower back or side pain
  • muscle pain
  • numbness, tingling, pain, or weakness in the hands or feet
  • painful or difficult urination
  • pale skin
  • shakiness in the legs, arms, hands, or feet
  • skin rash or itching
  • swelling of the feet or lower legs
  • swollen, painful, or tender lymph glands in the neck, armpit, or groin
  • tightness in the chest
  • trembling or shaking of the hands or feet
  • ulcers, sores, or white spots in the mouth
  • unusual bleeding or bruising
  • unusual tiredness or weakness
  • weakness in hands or feet

Rare

  • dark urine
  • light-colored stools
  • upper right abdominal or stomach pain
  • yellow eyes and skin

Get emergency help immediately if any of the following symptoms of overdose occur while taking hydralazine:

Symptoms of overdose

Other side effects of Apresoline

Some side effects of hydralazine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

  • diarrhea
  • loss of appetite
  • weight loss

Less common

  • constipation
  • difficulty with moving
  • dizziness
  • feeling anxious or depressed
  • muscle cramps, pain, or stiffness
  • pain in the joints
  • rash, hives, welts, or itching
  • stuffy nose
  • watery eyes

For healthcare professionals

Applies to hydralazine: compounding powder, injectable solution, oral tablet.

General

The most frequently reported side effects were palpitations and tachycardia.[Ref]

Cardiovascular

Gastrointestinal

Nervous system

Musculoskeletal

Metabolic

Immunologic

Respiratory

Hematologic

Renal

Dermatologic

Hepatic

Hypersensitivity

Genitourinary

Ocular

Other

Psychiatric

References

1. (2001) "Product Information. Apresoline (hydralazine)." Ciba-Geigy Pharmaceuticals

2. Cerner Multum, Inc. "UK Summary of Product Characteristics."

3. Cerner Multum, Inc. "Australian Product Information."

4. (2016) "Product Information. HydrALAZINE Hydrochloride (hydralazine)." Akorn Inc

Further information

Apresoline side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.